Catheter Precision (VTAK) has received a purchase order from Centre Hospitalier Universitaire de Rennes. This is the first purchase order from Universite de Rennes and marks the largest purchase order for the VIVO product line to date. CHU Rennes serves almost 500,000 patients annually with a mission of teaching, research and innovation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision forms new joint venture with Chelak iECG called Kardionav
- Catheter Precision’s LockeT Sales Surge in Q2 2025
- 3 Penny Stocks to Watch Now, 6/12/25
- Catheter Precision announces Q2 sales on track to be highest to date
- Catheter Precision Stock (VTAK) Rockets 170% on a Delayed Investor Reaction